111 Capital’s Teladoc Health TDOC Stock Holding History

111 Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,234	Closed	-$118K	–	526
2025 Q3	$118K	Buy	+15,234	New	+$119K	0.02%	433

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

111 Capital's TDOC Position: Q4 2025 in Review

111 Capital sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 15,234 shares — an estimated $118K sold.

111 Capital first reported a position in TDOC in Q3 2025 and held it in 1 quarter. The position peaked at $118K in Q3 2025. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

111 Capital reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
111 Capital sold 15,234 Teladoc Health shares in Q4 2025, an estimated $118K.
111 Capital first reported a position in Teladoc Health in Q3 2025 and held it in 1 quarter.
111 Capital's Teladoc Health position peaked at $118K in Q3 2025.
344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on 111 Capital's 13F filing for Q4 2025, filed 11 Feb 2026.